CClinicalTrials.gg
CompletedNCT06034873Updated Feb 6, 2026

Ultrasound Guided Pericapsular Nerve Block Versus iv Sedation Analgesia in Reduction of Shoulder Dislocation

A Phase 2 interventional study of Propofol injection and fentanyl and Bupivacain in Perioperative Pain, sponsored by Benha University. Completed at 1 site in Egypt. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-06.

Sponsored by Benha University · Phase 2, Interventional, and Treatment

Phase
Phase 2
Study type
Interventional
Enrollment
42
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

When someone experiences a shoulder dislocation, it can be extremely painful. Emergency physicians often choose to use conscious sedation to help reduce the pain. However, some patients may not be able to tolerate conscious sedation due to concerns about their ability to breathe properly or the risk of inhaling fluids. A recently developed technique called Ultrasound-guided Pericapsular Nerve Group (PENG) block is used to block the articular branches of the shoulder and the pericapsular spread around the glenohumeral joint. The PENG block is commonly used in hip surgery and is effective in providing motor-sparing analgesic results.

Read the detailed description

When someone experiences a shoulder dislocation, it can be extremely painful. Emergency physicians often choose to use conscious sedation to help reduce the pain. However, some patients may not be able to tolerate conscious sedation due to concerns about their ability to breathe properly or the risk of inhaling fluids. In an ideal scenario, the surgeon could achieve complete pain control and muscle relaxation without compromising the patient's airway. There are various techniques available to facilitate shoulder reduction, including interscalene block, general anesthesia, and intravenous analgesia. All of these methods can help the surgeon ease the patient's pain and reduce the likelihood of complications.1 When choosing the anesthesia method for reducing ASD, the top priority is ensuring the patient's comfort through pain management. The anesthesia helps to relax the muscle spasms, making it easier to reduce the ASD. The goal is to relocate the shoulder with minimal risk of complications.

A recently developed technique called Ultrasound-guided Pericapsular Nerve Group (PENG) block is used to block the articular branches of the shoulder and the pericapsular spread around the glenohumeral joint. The PENG block is commonly used in hip surgery and is effective in providing motor-sparing analgesic results.

02

Conditions studied

  • Perioperative Pain
03

In context

Lead sponsor

Benha University is the lead sponsor of 356 studies on the registry; 68 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • (ASA )classes I and II
  • patients of either sex, above the age of 18
  • patients will undergo dislocated shoulder

Exclusion criteria

Exclusion Criteria:

  • the patient's refusal to participate
  • coagulation disorders
  • allergy to local anesthetic
  • history of daily opioid intake
  • patients with cognitive impairments
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
42 participants (actual)

Study arms

  • Active comparator
    Group A

    In the IVAS group, the patients intravenous propofol combined with fentanyl. The sequence will be to inject fentanyl 1 μg•kg-1•min-1 first within 1 min and then inject propofol 2 mg•kg-1•min-1.

    Drug: Propofol injection and fentanyl

  • Active comparator
    Group B

    Patients will be anesthetized with ultrasound-guided pericapsular nerve group block (PENG block) using 20 ml of 0.25% bupivacaine.

    Drug: Bupivacain

Interventions

  • DrugPropofol injection and fentanyl

    The sequence will be to inject fentanyl 1 μg•kg-1•min-1 first within 1 min and then inject propofol 2 mg•kg-1•min-1.

    Also known as: deprivan

  • DrugBupivacain

    Patients will be anesthetized with ultrasound-guided pericapsular nerve group block (PENG block) using 20 ml of 0.25% bupivacaine.

    Also known as: markain

06

What researchers measure

Primary outcomes

  1. length of hospital stay

    the period when the patient stayed in the hospital

    Time frame: 1st 24 hours

Secondary outcomes

  1. reduction time

    the period from the beginning to the end of reduction

    Time frame: 1st hour after intervetion

  2. the visual analogue scale(VAS)

    ranges from 0 to 10, with 0 representing no pain and 10 being the most intense pain possible.

    Time frame: 30 minutes ,2,4,8,12 hours postoperative

07

Study locations

1 site
  • Banha faculity of medicine
    Banhā, Elqalyoubea 13511, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06034873
Lead sponsor
Benha University
Responsible party
Fatma Ahmed Abdel Fatah (lecturer of anaesthesia, Benha University) — Principal investigator
First posted
Sep 13, 2023
Start date
Nov 15, 2023
Primary completion
Sep 1, 2025
Completion
Oct 1, 2025
Last update
Feb 6, 2026

Study contacts

Fatma Ah Abdelfatah, MD
principal investigator · banha faculity of medicine

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion